I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Pratz, Keith W
60
results:
OpenAccess-fulltext X
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
Recent advances in targeted therapies in acute myeloid leuk..:
Bhansali, Rahul S
;
Pratz, Keith W
;
Lai, Catherine
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039574/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
2
Venetoclax combinations delay the time to deterioration of ..:
Pratz, Keith W
;
Panayiotidis, Panayiotis
;
Recher, Christian
...
qt1k1196kn. , 2022
Link:
https://escholarship.org..
?
3
Optimizing outcomes in secondary AML:
Matthews, Andrew
;
Pratz, Keith W
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820930/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
4
Outcomes in Patients with Poor-Risk Cytogenetics with or wi..:
Pollyea, Daniel A
;
Pratz, Keith W
;
Wei, Andrew H
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751752/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
5
Outcomes in Patients With Poor-risk Cytogenetics With or Wi..:
Pollyea, Daniel A
;
Pratz, Keith W
;
Wei, Andrew H
...
qt14k765pj. , 2022
Link:
https://escholarship.org..
?
6
Measurable Residual Disease Response and Prognosis in Treat..:
Pratz, Keith W
;
Jonas, Brian A
;
Pullarkat, Vinod
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906463/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
7
Real-world effectiveness of CPX-351 vs venetoclax and azaci..:
Matthews, Andrew H
;
Perl, Alexander E
;
Luger, Selina M
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278286/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
8
Postremission cytopenia management in patients with AML tre..:
Pratz, Keith W
;
DiNardo, Courtney D
;
Selleslag, Dominik
...
info:eu-repo/semantics/altIdentifier/pmid/36054316. , 2022
Link:
http://hdl.handle.net/21..
?
9
Impact of FLT3 Mutation on Outcomes after Venetoclax and Az..:
Konopleva, Marina
;
Thirman, Michael J
;
Pratz, Keith W
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365380/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
10
A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 ..:
Pratz, Keith W
;
Kaplan, Jason
;
Levy, Moshe
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973464/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
11
Measurable Residual Disease Response and Prognosis in Treat..:
Pratz, Keith W
;
Jonas, Brian A
;
Pullarkat, Vinod
...
qt3wh7c0cz. , 2022
Link:
https://escholarship.org..
?
12
Use of CYP3Ai and impact on outcomes in patients with acute..:
Jonas, Brian A
;
DiNardo, Courtney
;
Fracchiolla, Nicola
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286746/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
13
Measurable Residual Disease Response and Prognosis in Treat..:
Pratz, Keith W
;
Jonas, Brian A
;
Pullarkat, Vinod
...
Journal Of Clinical Oncology. -40 : 8 (2022), p. 855-865. -J. Clin. Oncol. - 0732-183X. - 1527-7755. , 2022
Link:
http://hdl.handle.net/24..
?
14
Cost-Effectiveness Analysis of Venetoclax in Combination wi..:
Pratz, Keith W
;
Chai, Xinglei
;
Xie, Jipan
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300490/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
15
Targeting Menin and CD47 to Address Unmet Needs in Acute My..:
Matthews, Andrew H
;
Pratz, Keith W
;
Carroll, Martin P
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735817/. , 2022
Link:
http://www.ncbi.nlm.nih...
1-15